Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure.

MLA

Rademaker, Miriam T., et al. “Four-Day Urocortin-I Administration Has Sustained Beneficial Haemodynamic, Hormonal, and Renal Effects in Experimental Heart Failure.” European Heart Journal, vol. 26, no. 19, Oct. 2005, pp. 2055–62. EBSCOhost, https://doi.org/10.1093/eurheartj/ehi351.

APA

Rademaker, M. T., Charles, C. J., Espiner, E. A., Frampton, C. M., Lainchbury, J. G., & Richards, A. M. (2005). Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure. European Heart Journal, 26(19), 2055–2062. https://doi.org/10.1093/eurheartj/ehi351

Chicago

Rademaker, Miriam T, Chris J Charles, Eric A Espiner, Chris M Frampton, John G Lainchbury, and A Mark Richards. 2005. “Four-Day Urocortin-I Administration Has Sustained Beneficial Haemodynamic, Hormonal, and Renal Effects in Experimental Heart Failure.” European Heart Journal 26 (19): 2055–62. doi:10.1093/eurheartj/ehi351.